Table 3.
Coefficient | B | SE | Wald | RR | 95% RR Odds CI | AOR | 95% AOR Odds CI |
---|---|---|---|---|---|---|---|
Age | 0.06 | 0.01 | 5.80 | 1.66***,! | [1.55, 2.24]! | 1.75***,! | [1.46, 2.12]! |
Gender | −1.41 | 0.54 | −2.60 | 0.26** | [0.08, 0.68] | 0.25** | [0.08, 0.66] |
Race | −0.09 | 0.28 | −0.34 | 0.91 | [0.54, 1.52] | 0.91 | [0.53, 1.58] |
BMI | −0.01 | 0.02 | −0.81 | 0.94& | [0.80, 1.10]& | 0.94& | [0.81, 1.09]& |
Immunodeficiency Syndromes | 1.49 | 0.36 | 4.13 | 3.67*** | [2.06, 5.88] | 4.42*** | [2.24, 9.28] |
Pulmonary Diseases | 0.76 | 0.31 | 2.49 | 2.00* | [1.18, 3.29] | 2.14* | [1.19, 3.98] |
Oncologic Diseases | −0.03 | 0.23 | −0.13 | 0.97 | [0.64, 1.46] | 0.97 | [0.62, 1.52] |
Gastrointestinal Diseases | −0.21 | 0.28 | −0.76 | 0.82 | [0.49, 1.35] | 0.81 | [0.47, 1.39] |
Renal Diseases | 0.39 | 0.24 | 1.62 | 1.45 | [0.93, 2.18] | 1.48 | [0.92, 2.39] |
Hematologic Diseases | 0.06 | 0.21 | 0.27 | 1.06 | [0.72, 1.53] | 1.06 | [0.70, 1.59] |
Endocrine Diseases | 0.60 | 0.19 | 3.09 | 1.77** | [1.23, 2.40] | 1.83** | [1.25, 2.69] |
Cardiovascular Diseases | −0.10 | 0.33 | −0.31 | 0.91 | [0.49, 1.64] | 0.90 | [0.47, 1.73] |
Neurologic Problems | 0.20 | 0.22 | 0.91 | 1.21 | [0.80, 1.79] | 1.22 | [0.79, 1.90] |
Lifetime Tobacco User | 0.82 | 0.24 | 3.42 | 2.25*** | [1.39, 3.10] | 2.28*** | [1.43, 3.68] |
Model Summary and Comparison Statistics | |||||||
R2MF | 0.25 | ||||||
ΔR2MF | 0.03 | ||||||
ΔΧ2 | 16.49*** |
Note. RR = Relative Risk; AOR = Adjusted Odds Ratio; Gender (0 = Male, 1 = Female); Race (0 = White, 1 = Non-White); BMI = Body Mass Index.
Pseudo r-square (1 − (Residual Deviance/Null Deviance)); ΔR2MF = Change in R2 between Model 1 and Model 2; ΔΧ2 = Chi-Square.
Difference test for comparison of model fit for Model 2 compared to Model 1.
= corresponds to a 10-year increase in age.
= corresponds to a 5 unit increase in BMI; R2MF = McFadden’s.
p < .05.
p < .01.
p < .001.